Speaker Profile

Vice President of Business Development, MMRF

Biography
Christopher Williams was named Vice President of Business Development at the MMRF in 2017, responsible for business development, partnership and joint venture efforts for the foundation. He is a business development leader with a strong scientific background, specializing in the pharmaceutical and diagnostics space. Most recently he served as the VP of Business Development at WaveSense where he was in charge of their US commercialization strategy and product expansion, as well as being responsible for overseeing their strategic partner relationships. Previously Chris was VP of Business Development at SkylineDx, providing commercialization strategy for their oncology portfolio. With PerkinElmer, as the Market Segment Leader in Oncology, he had responsibility for their cancer diagnostic products including strategy, launch activities, external presentations and marketing execution. While at Millennium Pharmaceuticals, Chris held roles in the Protein Science, Technology Development and Proteomics groups. He also had scientific roles at Schering-Plough and the Sandoz Research Institute. Chris holds graduate and post-graduate degrees in Microbiology/Molecular Biology and Protein Biochemistry from Clemson University.


AI and Data Sciences Showcase:
MMRF

A pioneer in precision medicine, the Multiple Myeloma Research Foundation (MMRF) seeks to find a cure for every multiple myeloma patient by relentlessly pursuing innovations that accelerate the development of precision treatments for cancer.

Innovation Of Patient-Centered Research Initiatives: MMRF CureCloud
The first-of-its-kind, innovative MMRF CureCloud research study features direct-to-patient enrollment, the first at-home CLIA-grade cfDNA sequencing test for myeloma, and real-world EHR data collection to deliver real-time insights back to patients and their physicians to inform clinical decision-making.

 Session Abstract – PMWC 2022 Silicon Valley


Track Chair:
Keith Yamamoto, UCSF

Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support

Sessions:

  • Realizing the Promise of Precision Medicine Using Real-world Evidence (PANEL)
    Session Chair: Atul Butte, UCSF
    - Nancy A. Dreyer, IQVIA
    - Mark Laabs, RCRF
    - Rhonda Cooper-DeHoff, University of Florida
    - Chris Boone, Abbvie
  • Opportunities and Challenges in Using Real World Data (RWD) (PANEL)
    Session Chair: Vivek Rudrapatna, UCSF
    - Mark Hoffman, Childrens Mercy Hospital
    - Ida Sim, UCSF
    - Julian Hong, UCSF
  • How Are Patient Data Revolutionizing Precision Medicine? (PANEL)
    Session Chair: Clara Lajonchere, UCLA
    - Sharon Terry, Genetic Alliance
    - Farid Vij, Invitae
    - Latha Palaniappan, Stanford
  • Government Partnerships: California Initiative to Advance Precision Medicine
    Session Chair: Julianne McCall, California Initiative to Advance Precision Medicine
    - William Kim, UCSD
    - Mike Snyder, Stanford
  • Leveraging RWE to Create Value (PANEL)
    Session Chair: Latha Palaniappan, Stanford
    - Brook Schroeder, Illumina
    - Suzanne Belinson, Tempus
    - Stacey Dacosta Byfield, Optum Genomics
  • Computational Social Choice Theory's Impact on the Collection and Understanding of RWD
    - Ian Terry, LunaDNA
  • PMWC Showcase
    - Chris Williams, MMRF
    - Jason Crites, Assurance Health Data